Summary

Eligibility
for females ages up to 45 years (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UC Davis
Dates
study started
study ends around

Description

Summary

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Official Title

A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept™, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability

Details

Keywords

Women at Risk for Pregnancy, VeraCept

Eligibility

Locations

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Sebela Women's Health Inc.
ID
NCT03633799
Phase
Phase 3 Pregnancy Research Study
Study Type
Interventional
Participants
About 1620 people participating
Last Updated